Literature DB >> 11606058

Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF.

S Tsutsumi1, A Shimazu, K Miyazaki, H Pan, C Koike, E Yoshida, K Takagishi, Y Kato.   

Abstract

Mesenchymal stem cells (MSC) that can differentiate to various connective tissue cells may be useful for autologous cell transplantation to defects of bone, cartilage, and tendon, if MSC can be expanded in vitro. However, a short life span of MSC and a reduction in their differentiation potential in culture have limited their clinical application. The purpose of this study is to identify a growth factor(s) involved in self-renewal of MSC and the maintenance of their multilineage differentiation potential. Fibroblast growth factor-2 (FGF-2) markedly increased the growth rate and the life span of rabbit, canine, and human bone marrow MSC in monolayer cultures. This effect of FGF-2 was more prominent in low-density cultures than in high-density cultures. In addition, all MSC expanded in vitro with FGF-2, but not without FGF-2, differentiated to chondrocytes in pellet cultures. The FGF+ MSC also retained the osteogenic and adipogenic potential throughout many mitotic divisions. These findings suggest that FGFs play a crucial role in self-renewal of MSC. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606058     DOI: 10.1006/bbrc.2001.5777

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  155 in total

1.  NOTCH-Mediated Maintenance and Expansion of Human Bone Marrow Stromal/Stem Cells: A Technology Designed for Orthopedic Regenerative Medicine.

Authors:  Yufeng Dong; Teng Long; Cuicui Wang; Anthony J Mirando; Jianquan Chen; Regis J O'Keefe; Matthew J Hilton
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

Review 2.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

3.  Xeno-free proliferation of human bone marrow mesenchymal stem cells.

Authors:  Hiroto Miwa; Yoshiki Hashimoto; Keiji Tensho; Shigeyuki Wakitani; Mutsumi Takagi
Journal:  Cytotechnology       Date:  2011-10-15       Impact factor: 2.058

Review 4.  Translating tissue-engineered tracheal replacement from bench to bedside.

Authors:  Madhuri Kalathur; Silvia Baiguera; Paolo Macchiarini
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

5.  Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells.

Authors:  Jin Yu Liu; Hao Fan Peng; Siddhita Gopinath; Jun Tian; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

6.  Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived mesenchymal stem cells.

Authors:  R Ramasamy; C K Tong; W K Yip; S Vellasamy; B C Tan; H F Seow
Journal:  Cell Prolif       Date:  2012-02-06       Impact factor: 6.831

Review 7.  Age-associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair.

Authors:  Bin Yao; Sha Huang; Dongyun Gao; Jiangfan Xie; Nanbo Liu; Xiaobing Fu
Journal:  Int Wound J       Date:  2015-10-01       Impact factor: 3.315

Review 8.  The Role of the Microenvironment in Controlling the Fate of Bioprinted Stem Cells.

Authors:  Lauren N West-Livingston; Jihoon Park; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Chem Rev       Date:  2020-06-19       Impact factor: 60.622

9.  ROCK Inhibition Promotes the Development of Chondrogenic Tissue by Improved Mass Transport.

Authors:  Kuo-Chen Wang; Thomas T Egelhoff; Arnold I Caplan; Jean F Welter; Harihara Baskaran
Journal:  Tissue Eng Part A       Date:  2018-04-23       Impact factor: 3.845

10.  Inhibition of gamma-secretases alters both proliferation and differentiation of mesenchymal stem cells.

Authors:  S Vujovic; S R Henderson; A M Flanagan; M O Clements
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.